%PDF-1.4
%
1 0 obj
<<
/Pages 2 0 R
/OpenAction [3 0 R /XYZ 0 841.9000244141 0]
/PageLabels 4 0 R
/PageMode /UseNone
/Metadata 5 0 R
/Type /Catalog
>>
endobj
4 0 obj
<<
/Nums [0 6 0 R]
>>
endobj
3 0 obj
<<
/TrimBox [0 0 595.2760009766 841.8900146484]
/MediaBox [0 0 595.2760009766 841.8900146484]
/CropBox [0 0 595.2760009766 841.8900146484]
/Resources 7 0 R
/Contents [8 0 R 9 0 R 10 0 R 11 0 R]
/Parent 2 0 R
/BleedBox [0 0 595.2760009766 841.8900146484]
/Annots [12 0 R 13 0 R 14 0 R]
/Type /Page
>>
endobj
5 0 obj
<<
/Subtype /XML
/Length 3507
/Type /Metadata
>>
stream
Courtney Davis, Joel Lexchin, Tom Jefferson, Peter Gøtzsche, Martin McKeebmj.comfalse10.1136/bmj.i4437“Adaptive pathways” to drug authorisation: adapting to industry?2016-08-16
10.1136/bmj.i4437http://dx.doi.org/doi:10.1136/bmj.i4437
doi:10.1136/bmj.i4437
2016-08-16falsebmj.com10.1136/bmj.i4437
endstream
endobj
2 0 obj
<<
/ITXT (5.1.3)
/Kids [3 0 R 15 0 R 16 0 R 17 0 R]
/Count 4
/Type /Pages
>>
endobj
6 0 obj
<<
/S /D
>>
endobj
8 0 obj
<<
/Filter /FlateDecode
/Length 10
>>
stream
x+ |
endstream
endobj
9 0 obj
<<
/Filter /FlateDecode
/Length 44
>>
stream
x+2P0P24327slC=K %
endstream
endobj
10 0 obj
<<
/Filter /FlateDecode
/Length 8655
>>
stream
xڭ]YsǑ~篘ؐe{m7j6! p(EA"mIJ
plf
{PЀTe]YYyWf,{SzHwї.7䛐7c|Ԟ/ك{faųob]xo27|Oc?qq_oueuتr?}~^`IN8%%s\Es'u#3tH/y-)?;8-=/TB SI,pumV\"|;%2nIw)V3ɒ2?^17oIigaWm bȧN6oV{6t1
:Xu&XXJ㭠r14zB9,1P{o8̞/]r&u'(ΛWƅ:w$ѓtuK/a`gJVPaOGqלsR2frgՎ<_Slp,.6{ӥRNQ\8=:EN)=ǃsqG$xNgX3\qlGG
F'-QPXm?C7/\1R?kÄ;`Bd8eg
t-oQ \7g/7gvL=gKJ=6=.F1 aYC$םDǰCMLFlEJӡ/! :t
;ٯp(Gx4*MN enY)wZZmz>eV/4KOj,tLO͉ :Brzr,0&`J
Ǟu=zcF=X䲍:XtVy9t6CS|٣ssЃuV5nV8X}GEJOM2҃nۀ6H"w}JHf6p@C0+%6zQ*gh?w/plt?0⎌4:f2u@er!M~h
V9uB$7j*|huc7Lu1
h4^1)Z(-AѪK]Q)Y>UtLlb\}«J^Ume8*|.}c`k?nuw} q0KM8[YbD%Aq* 0QLA[ܒ$۳J_9JsT'lS%
f(ġOvŠ{DMZ93 Uhl$#:-1=& ]Pl~cq3Eyg[Y[Q=Mx